Viewpoint News & Awards

Michael Graham, MD PhD

Michael Graham, MD PhD has been a leader in nuclear medicine and radiopharmaceuticals for over 30 years. Dr. Graham is a Professor of Radiology at the University of Iowa; a former President of the Society of Nuclear Medicine; and a current Co-Chair of the SNMMI Clinical Trials Network, which is an SNMMI entity that has been specifically formed to assist early stage companies in accelerating new radiopharmaceuticals through clinical stages of development. Dr. Graham has been a Principal Investigator on multiple IND filings and has recently provided leadership in securing an NDA for gallium-68 DOTATOC for imaging of neuroendocrine tumors through his efforts at the Clinical Trials Network. Dr. Graham earned a BS in Engineering from Massachusetts Institute of Technology; a PhD from University of California, Berkeley; and an MD from the University of California San Francisco. He served as Head of Nuclear Medicine at the University of Iowa for over a decade and is a world-renown content expert in image-guided radionuclide therapy for cancer and clinical trial design for this application.